Home NDC 70370-3050 ONGENTYS
Product NDC 70370-3050
11-digit product format 703703050
Labeler code 70370
Product ID 70370-3050_62cbc1fe-da3b-436f-ba28-5dca7becb528
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name opicapone
Dosage form CAPSULE
Route ORAL
Labeler Neurocrine Biosciences, Inc.
Application NDA212489
Marketing category NDA
Marketing start 2020-04-24
Marketing end 0000-00-00
Substance OPICAPONE
Active strength 50 mg/1
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 33 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N212489-001 ONGENTYS OPICAPONE 25MG CAPSULE / ORAL RLD 2020-04-24 N212489-002 ONGENTYS OPICAPONE 50MG CAPSULE / ORAL RLD, RS 2020-04-24
Orange Book patents# Current patent rows page 1 of 1 · 22 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N212489-001 9550759 2026-07-26 U-3870 2020-05-19 N212489-001 9550759 2026-07-26 U-3871 2020-05-19 N212489-001 9550759 2026-07-26 U-3872 2020-05-19 N212489-001 8907099 2027-05-12 Drug substance 2020-05-19 N212489-001 8168793 2027-10-10 U-3869 Drug substance, Drug product 2020-05-19 N212489-001 9745290 2027-10-10 U-3869 Drug product 2020-05-19 N212489-001 8524746 2029-07-14 U-3869 2020-05-19 N212489-001 10071085 2030-03-31 Drug product 2020-05-19 N212489-001 10583130 2030-03-31 U-3869 2020-05-19 N212489-001 12129247 2032-01-11 U-4038 2024-11-26 N212489-001 9630955 2032-12-12 U-3869 Drug substance, Drug product 2020-05-19 N212489-002 9550759 2026-07-26 U-3870 2020-05-19 N212489-002 9550759 2026-07-26 U-3871 2020-05-19 N212489-002 9550759 2026-07-26 U-3872 2020-05-19 N212489-002 8907099 2027-05-12 Drug substance 2020-05-19 N212489-002 8168793 2027-10-10 U-3869 Drug substance, Drug product 2020-05-19 N212489-002 9745290 2027-10-10 U-3869 Drug product 2020-05-19 N212489-002 8524746 2029-07-14 U-3869 2020-05-19 N212489-002 10071085 2030-03-31 Drug product 2020-05-19 N212489-002 10583130 2030-03-31 U-3869 2020-05-19 N212489-002 12129247 2032-01-11 U-4038 2024-11-26 N212489-002 9630955 2032-12-12 U-3869 Drug substance, Drug product 2020-05-19
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 78 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N212489-001 ONGENTYS 25MG CAPSULE / ORAL RLD 2020-04-24 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N212489-002 ONGENTYS 50MG CAPSULE / ORAL RLD, RS 2020-04-24 bb7c543d1eb4…
Observed Orange Book patent history# Patent history page 1 of 22 · 844 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N212489-001 9550759 2026-07-26 U-3870 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 9550759 2026-07-26 U-3871 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 9550759 2026-07-26 U-3872 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 8907099 2027-05-12 Drug substance 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 8168793 2027-10-10 U-3869 Drug substance, Drug product 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 9745290 2027-10-10 U-3869 Drug product 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 8524746 2029-07-14 U-3869 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 10071085 2030-03-31 Drug product 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 10583130 2030-03-31 U-3869 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 12129247 2032-01-11 U-4038 2024-11-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-001 9630955 2032-12-12 U-3869 Drug substance, Drug product 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 9550759 2026-07-26 U-3870 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 9550759 2026-07-26 U-3871 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 9550759 2026-07-26 U-3872 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 8907099 2027-05-12 Drug substance 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 8168793 2027-10-10 U-3869 Drug substance, Drug product 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 9745290 2027-10-10 U-3869 Drug product 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 8524746 2029-07-14 U-3869 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 10071085 2030-03-31 Drug product 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 10583130 2030-03-31 U-3869 2020-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 12129247 2032-01-11 U-4038 2024-11-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212489-002 9630955 2032-12-12 U-3869 Drug substance, Drug product 2020-05-19 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212489-001 9550759 2026-07-26 U-3870 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 9550759 2026-07-26 U-3871 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 9550759 2026-07-26 U-3872 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 8907099 2027-05-12 Drug substance 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 8168793 2027-10-10 U-3869 Drug substance, Drug product 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 9745290 2027-10-10 U-3869 Drug product 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 8524746 2029-07-14 U-3869 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 10071085 2030-03-31 Drug product 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 10583130 2030-03-31 U-3869 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 12129247 2032-01-11 U-4038 2024-11-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-001 9630955 2032-12-12 U-3869 Drug substance, Drug product 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-002 9550759 2026-07-26 U-3870 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-002 9550759 2026-07-26 U-3871 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-002 9550759 2026-07-26 U-3872 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-002 8907099 2027-05-12 Drug substance 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-002 8168793 2027-10-10 U-3869 Drug substance, Drug product 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-002 9745290 2027-10-10 U-3869 Drug product 2020-05-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212489-002 8524746 2029-07-14 U-3869 2020-05-19 caaa826d4ba7…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 70 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ONGENTYS OPICAPONE Amneal Pharmaceuticals LLC a511a531-112e-43f8-a43f-5334b0efe979 2025-10-15 Warnings, Adverse reactions Exact identifier application applno (NDA): 212489 application number: NDA212489
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70370-3050-2 70370305002 30 CAPSULE in 1 BOTTLE (70370-3050-2) 30 capsule 2020-04-24 0000-00-00 No No Current